Jiaxin Shen
-
- IL-33, ST2, and ILC Pathways 2
-
- MicroRNA in disease regulation 2
-
- Nanoparticle-Based Drug Delivery 3
-
- Nanoplatforms for cancer theranostics 5
-
- Pregnancy and preeclampsia studies 4
- Gestational Diabetes Research and Management 4
-
- Birth, Development, and Health 3
-
- Eosinophilic Esophagitis 2
Jiaxin Shen
35 papers receiving 680 citations
Peers
Comparison fields: 5 of 99
- Immunology 203
- Cancer Research 96
- Immunology and Allergy 31
- Biomaterials 64
- Oncology 123
Countries citing papers authored by Jiaxin Shen
This map shows the geographic impact of Jiaxin Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxin Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxin Shen more than expected).
Fields of papers citing papers by Jiaxin Shen
This network shows the impact of papers produced by Jiaxin Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxin Shen. The network helps show where Jiaxin Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiaxin Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 55 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 8 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 21 | |
| 11 | 2023 | 5 | |
| 12 | Comparison of Pull and Introducer Techniques for Percutaneous Endoscopic Gastrostomy | 2022 | 0 |
| 13 | 2022 | 5 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 20 | |
| 18 | Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. | 2018 | 181 |
| 19 | 2018 | 47 | |
| 20 | 2018 | 9 |
About Jiaxin Shen
Jiaxin Shen is a scholar working on Obstetrics and Gynecology, Family Practice and Immunology, having authored 41 papers that have together received 686 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Pregnancy and preeclampsia studies (4 papers), Gestational Diabetes Research and Management (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Birth, Development, and Health (3 papers), Eosinophilic Esophagitis (2 papers), MicroRNA in disease regulation (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). The work is most often cited by research in Immunology (203 citations), Cancer Research (96 citations) and Immunology and Allergy (31 citations). Jiaxin Shen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guo‐Jun Zhang, Wen-Jia Chen, Xiaoli Li, Caiwen Du, Jing Liu, Hua-Tao Wu, Julia Kzhyshkowska, Irina Larionova, Jing Liu and Jing Liu. Their work appears in journals such as Frontiers in Immunology, Journal of Nanobiotechnology, World Neurosurgery, Journal of Multidisciplinary Healthcare and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.